🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Multi Vessel Coronary Artery Disease

Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. NCT07048808Phase 214 sites📍 Birmingham📍 Phoenix📍 Atlanta XyloCor Therapeutics, Inc. · Tests: XC001, Sham (No Treatment) First-in-Human Study Using the SiroMax™ Sirolimus-Coated Balloon Catheter as a Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter to Treat Subjects Who Have Coronary Artery Disease (CAD) Involving In-Stent Restenosis (ISR) or an Unstented Lesion in a Small Coronary Vessel (DNSV). NCT07811024NA2 sites📍 Tashkent📍 Tashkent Tonic Medical, Inc. · Tests: Sirolimus-coated balloon catheter, Sirolimus-coated balloon catheter Prospective Coronary Heart Disease Cohort NCT05699629n/a1 site📍 Jinan Shandong First Medical University Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis NCT06885619n/a1 site📍 Beijing Beijing Anzhen Hospital · Tests: Diagnostic Test: echocardiography and blood collection Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina NCT03789552Phase 31 site📍 Naples Tasly Pharmaceuticals, Inc. · Tests: T89 capsule, Placebo capsule A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease NCT07214376NA18 sites📍 Tucson📍 New Haven📍 Weston Pulnovo Medical, Inc. · Tests: Pulmonary Artery Denervation (PADN), Sham procedure control SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study NCT05770687n/a1 site📍 Seoul Kiyuk Chang · Tests: SGLT2 inhibitor Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy NCT04416581Phase 445 sites📍 Anyang📍 Bucheon-si📍 Busan Duk-Woo Park, MD · Tests: PPI, P-CAB 50 Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI NCT07160491NA1 site📍 Shenyang Shenyang Northern Hospital · Tests: A novel artificial intelligence assisted mobile application Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics NCT06001073n/a1 site📍 Xi'an First Affiliated Hospital Xi'an Jiaotong University · Tests: Observational; No Interventions were given. Percutaneous Coronary RevascularizatiOn VERsus Coronary-Artery Bypass Grafting for Multivessel Disease in Patients With Left Ventricular Dysfunction (PROVERB) NCT05532631NA1 site📍 Créteil Assistance Publique - Hôpitaux de Paris · Tests: Percutaneous coronary intervention, Coronary artery bypass grafting Multivessel Balloon Occlusion to Investigate Obstructive Coronary Artery Disease and aNgina NCT06400290NA9 sites📍 Basildon📍 Bournemouth📍 Brighton Imperial College London · Tests: Percutaneous coronary intervention (PCI), Symptom assessment during experimentally induced ischaemia Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women NCT04124120NA146 sites📍 Los Angeles📍 Pomona📍 San Francisco Weill Medical College of Cornell University · Tests: Single arterial graft, Multiple arterial grafting Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD NCT07539324NA1 site📍 Ulsan Genoss Co., Ltd. · Tests: GENOSS® DCB (Paclitaxel-coated PTCA balloon catheter), Contemporary Drug-Eluting Stents (DES) Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting NCT06141525NA1 site📍 Xi'an First Affiliated Hospital Xi'an Jiaotong University · Tests: Remote ischemic conditioning The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease NCT04505865NA1 site📍 Boston Massachusetts General Hospital · Tests: Stress Reduction Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients NCT07180368n/a1 site📍 Xi'an Xijing Hospital Randomization of Single vs Multiple Arterial Grafts NCT03217006NA59 sites📍 Boulder📍 Springfield📍 Lincoln Weill Medical College of Cornell University · Tests: Single arterial graft, Multiple arterial grafting Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) NCT04278404n/a52 sites📍 Phoenix📍 Little Rock📍 Los Angeles Duke University · Tests: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the fol… Tezspire Cardiac Events PASS NCT06951867n/a4 sites📍 Wilmington📍 Copenhagen📍 Paris AstraZeneca · Tests: Tezepelumab Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) NCT06577519Phase 31 site📍 Shenyang Jiangsu vcare pharmaceutical technology co., LTD · Tests: Vicagrel, Clopidogrel A Study on the Peripheral Blood in Patients With Acute Coronary Syndrome NCT06955143n/a1 site📍 Lishui Second Affiliated Hospital of Wenzhou Medical University Virtue® SAB in the Treatment of Coronary ISR Trial NCT07045194NA22 sites📍 Phoenix📍 Gainesville📍 Hollywood Orchestra BioMed, Inc · Tests: Virtue Sirolimus AngioInfusion Balloon, AGENT™ Paclitaxel Drug-Coated Balloon Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator NCT05527717Phase 41 site📍 Seoul Samsung Medical Center · Tests: Culprit lesion only PCI, Immediate multi-vessel PCI CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2) NCT07165678NA1 site📍 London Queen Mary University of London · Tests: CTCA EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality NCT03987633n/a1 site📍 Wolverhampton Future Genetics Limited Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI) NCT04968808NA1 site📍 Gwangju Chonnam National University Hospital · Tests: Staged in-hospital complete revascularization, Immediate complete revascularization Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock NCT05185492n/a3 sites📍 Weston📍 Falls Church📍 Toronto STAVROS G DRAKOS Single-cell Multi-omics Analyses of OCT-diagnosed Plaque Subtypes in Coronary Artery Disease (MOOP-CAD) NCT06489119n/a2 sites📍 Harbin📍 Changchun Harbin Medical University
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy